Arch Biopartners Inc
XTSX:ARCH

Watchlist Manager
Arch Biopartners Inc Logo
Arch Biopartners Inc
XTSX:ARCH
Watchlist
Price: 1.24 CAD 2.48%
Market Cap: 83m CAD

Wall Street
Price Targets

ARCH Price Targets Summary
Arch Biopartners Inc

There are no price targets for ARCH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Arch Biopartners Inc Competitors:
Price Targets
603108
Shanghai Runda Medical Technology Co Ltd
62% Upside
CSBR
Champions Oncology Inc
74% Upside
MEDP
Medpace Holdings Inc
3% Downside
TMO
Thermo Fisher Scientific Inc
12% Upside
RGEN
Repligen Corp
17% Upside
STVN
Stevanato Group SpA
41% Upside
QGEN
Qiagen NV
14% Upside
ADPT
Adaptive Biotechnologies Corp
22% Upside

Revenue
Forecast

Revenue Estimate
Arch Biopartners Inc

The compound annual growth rate of Arch Biopartners Inc's revenue for the next 4 years is 152%.

N/A
Past Growth
152%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Arch Biopartners Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-59%
Average Miss

Net Income
Forecast

Net Income Estimate
Arch Biopartners Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ARCH's stock price target?
Not Available

ARCH doesn't have any price targets made by Wall Street professionals.

What is Arch Biopartners Inc's Revenue forecast?
Projected CAGR
152%

The compound annual growth rate of Arch Biopartners Inc's revenue for the next 4 years is 152%.

Back to Top